Circe Biosciences
Developing a manufacturing platform capable of producing any organic molecule using carbon dioxide, water, and electricity.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD49—74m (Dealroom.co estimates May 2024.)
Boston Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $3.0m | Grant | |
N/A | Spinout | ||
N/A | Support Program | ||
* | $8.0m | Early VC | |
| Total Funding | AUD17.0m | ||